☆ 4.6 Article

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro

PHARMACEUTICALS (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: anin silicodocking and molecular dynamics simulation approach

Ranabir Majumder et al.

Summary: This study investigates potential inhibitors of COVID-19 M(pro) and screens out several natural compounds through virtual molecular docking and molecular dynamics simulation. The results show that these natural compounds have high binding affinity to COVID-19 M(pro) and possess important dynamic properties such as stability and flexibility. However, further preclinical and clinical trials are needed to validate these compounds.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease

Chinmayee Choudhury

Summary: This study designed novel molecules targeting the main protease of SARS-CoV-2, which is crucial for viral replication, using computational methods. These molecules showed promising binding affinities and interactions with the virus, making them potential starting points for drug discovery against COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

添加到收藏夹

Article Chemistry, Medicinal

QSAR Modeling of SARS-CoV MproInhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and Other Drugs as Candidates for Repurposing against SARS-CoV-2

Vinicius M. Alves et al.

Summary: The researchers conducted virtual screening of inhibitors of the M-protease using QSAR models, and validated the effectiveness of some compounds in subsequent experiments. The results demonstrate that the models effectively guided experimental investigations of potential anti-COVID-19 drug candidates.

MOLECULAR INFORMATICS (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection

Xiao-huan Liu et al.

Summary: This review discusses the high pathogenicity and mortality rates of pathogenic coronaviruses such as SARS-CoV and MERS-CoV, emphasizing the importance of accelerating the development of novel antiviral drugs, and presents the potential and recent advances in target-based drug development.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19

Divya M. Teli et al.

Summary: This study investigates the antiviral potential of various plant compounds against SARS-CoV-2, with solanine, acetoside, and rutin identified as promising dual inhibitors for both Mpro and spike glycoprotein RBD. Acetoside and curcumin were found to inhibit Mpro covalently, with curcumin showing favorable physicochemical and pharmacokinetic properties for potential development as a treatment option against COVID-19.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening

Christoph Gorgulla et al.

Summary: The global effort to combat the ongoing COVID-19 pandemic has led to promising prophylactic measures, but there is still a need for effective therapeutics. Through a large-scale virtual screening platform, inhibitors targeting SARS-CoV-2 are being searched for, focusing on both viral enzymes' active sites and critical protein-protein interactions.

ISCIENCE (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story

Amin Gasmi et al.

Summary: Chloroquine and hydroxychloroquine are considered promising agents against the new coronavirus, with antiviral effects demonstrated in vitro. These drugs can reduce immune reactions, inhibit inflammation, and potentially treat viral infections and related ailments. Studies are ongoing to determine their efficacy and safety in treating COVID-19.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)

添加到收藏夹

Letter Multidisciplinary Sciences

Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors

Chunlong Ma et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation

Sheng Guo et al.

Summary: SARS-CoV-2, the pathogen responsible for the 2020 global COVID-19 outbreak, has seen progress in vaccine and antiviral drug development. Two active main protease inhibitors were discovered through docking-based virtual screening and bioassay, with potential implications for future drug design. The findings in this work shed light on the interactions between main protease and inhibitors, offering insight into post-infection treatment options.

BIOORGANIC CHEMISTRY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease

Sebastian Guenther et al.

Summary: The study identified 37 compounds that bind to the SARS-CoV-2 main protease through a high-throughput x-ray crystallographic screen of two repurposing drug libraries. Among these compounds, one peptidomimetic and six nonpeptidic compounds showed antiviral activity in cell-based viral reduction assays at nontoxic concentrations. The identification of two allosteric binding sites presents potential targets for drug development against SARS-CoV-2.

SCIENCE (2021)

添加到收藏夹

Review Medicine, General & Internal

Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review

Ahmed Wadaa-Allah et al.

Summary: Through synthesizing and summarizing existing research evidence, Favipiravir and Hydroxycholoroquine were found to effectively shorten the viral clearance and clinical recovery time of COVID-19 patients, while Lopinavir-ritonavir, convalescent plasma transfusion, and anticoagulant therapies offer better prognosis. Remdesivir, Tocilizumab, Immunoglobulin, and Mesenchymal stem cell transplantation showed promising treatment results but require further confirmatory studies.

ANNALS OF MEDICINE (2021)

添加到收藏夹

Article Chemistry, Organic

Direct C-S Bond Functionalization of Benzyl Mercaptan

Khokan Choudhuri et al.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design

Maria Bzowka et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds

Andre Fischer et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

添加到收藏夹

Article Chemistry, Medicinal

COVID-19: Drug Targets and Potential Treatments

Carmen Gil et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Biology

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors

Alicia Jimenez-Alberto et al.

COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Putative SARS-CoV-2 MproInhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study

Stefania Mazzini et al.

MOLECULES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs

Zhe Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Virology

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

Mohamed Mahdi et al.

VIROLOGY JOURNAL (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial

Yueping Li et al.

MED (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

Gamal El-Din A. Abuo-Rahma et al.

RSC ADVANCES (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

The nature of ligand efficiency

Peter W. Kenny

JOURNAL OF CHEMINFORMATICS (2019)

添加到收藏夹

Review Biophysics

Ensemble Docking in Drug Discovery

Rommie E. Amaro et al.

BIOPHYSICAL JOURNAL (2018)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study

Li Wang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Simple synthesis of glycosylthiols and thioglycosides by rearrangement of O-glycosyl thionocarbamates

R. Komor et al.

CARBOHYDRATE RESEARCH (2014)

添加到收藏夹

Article Chemistry, Organic

SIMPLE AND EFFICIENT METHOD FOR THE PROTECTION OF HYDROXYL GROUPS AS 4-METHOXYBENZYL ETHERS

Anna Kasprzycka et al.

SYNTHETIC COMMUNICATIONS (2014)

添加到收藏夹

Article Chemistry, Medicinal

Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise

David Ryan Koes et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

H++3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations

Ramu Anandakrishnan et al.

NUCLEIC ACIDS RESEARCH (2012)

添加到收藏夹

Article Chemistry, Multidisciplinary

Gabedit-A Graphical User Interface for Computational Chemistry Softwares

Abdul-Rahman Allouche

JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling

Jianing Li et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)

添加到收藏夹

Article Chemistry, Multidisciplinary

Open Babel: An open chemical toolbox

Noel M. O'Boyle et al.

JOURNAL OF CHEMINFORMATICS (2011)

添加到收藏夹

Article Biophysics

Accounting for Ligand Conformational Restriction in Calculations of Protein-Ligand Binding Affinities

Cen Gao et al.

BIOPHYSICAL JOURNAL (2010)

添加到收藏夹

Article Chemistry, Medicinal

A Medicinal Chemist's Guide to Molecular Interactions

Caterina Bissantz et al.

JOURNAL OF MEDICINAL CHEMISTRY (2010)

添加到收藏夹

Article Plant Sciences

Thiodiketopiperazines Produced by the Endophytic Fungus Epicoccum nigrum

Jia-Ming Wang et al.

JOURNAL OF NATURAL PRODUCTS (2010)

添加到收藏夹

Article Plant Sciences

Diketopiperazines from the Cordyceps-Colonizing Fungus Epicoccum nigrum

Huijuan Guo et al.

JOURNAL OF NATURAL PRODUCTS (2009)

添加到收藏夹

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening

TA Halgren et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Protein Data Bank

HM Berman et al.

NUCLEIC ACIDS RESEARCH (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.